Arimidex 1 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6SU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,798
Award facts
- Contract value 100% obligated
- $12,797.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,797.91 to AmerSourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on February 4, 2026, with an ultimate completion date of February 5, 2026. This firm fixed-price, non-set-aside contract is being performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a task order issued under AmerSourceBergen's parent company, Cencora, Inc.'s, substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary procurement vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, continues to demonstrate its capability to fulfill federal medical procurement requirements through competitive procurement mechanisms. The company's extensive portfolio with the Defense Logistics Agency encompasses a wide spectrum of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This delivery order for Arimidex, a hormonal cancer treatment medication, exemplifies the company's critical role in supplying essential pharmaceuticals to military treatment facilities and other federal medical institutions as part of the DLA's comprehensive medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26F6SU5?
SPE2DR26F6SU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26F6SU5 worth?
The government has obligated $12,798 on SPE2DR26F6SU5.
Is contract SPE2DR26F6SU5 an order under another contract?
Yes. SPE2DR26F6SU5 is a delivery order under SPE2DR25D2108, an indefinite delivery contract.
Was contract SPE2DR26F6SU5 competed?
The extent of competition for SPE2DR26F6SU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award